Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changmeng Cai

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Cancer Cell|October 22, 2011
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1Changmeng Cai, Housheng Hansen He, Sen Chen, et al.
Oncogene|January 3, 2022
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibitionWanting Han, Mingyu Liu, Dong Han, et al.
Nucleic Acids Research|January 8, 2017
Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancerXiaming Liu, Yanfei Gao, HuiHui Ye, et al.
Molecular Cancer Therapeutics|March 21, 2025
Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient CellsMaryam Labaf, Wanting Han, Songqi Zhang, et al.
Cancer Research|March 6, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate CancerMuqing Li, Mingyu Liu, Wanting Han, et al.
Cell Reports|October 21, 2016
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma ProteinShuai Gao, Yanfei Gao, Housheng Hansen He, et al.
The Journal of Clinical Investigation|April 5, 2016
SOX9 drives WNT pathway activation in prostate cancerFen Ma, Huihui Ye, Housheng Hansen He, et al.
Cancer Research|August 27, 2011
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitorsChangmeng Cai, Sen Chen, Patrick Ng, et al.
The Journal of Clinical Investigation|February 22, 2013
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerChangmeng Cai, Hongyun Wang, Housheng Hansen He, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Molecular Cancer Research : MCR|May 4, 2017
Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155Michael D Nyquist, Alexandra Corella, John Burns, et al.
Cancer Cell|October 22, 2011
Androgen receptor gene expression in prostate cancer is directly suppressed by the androgen receptor through recruitment of lysine-specific demethylase 1Changmeng Cai, Housheng Hansen He, Sen Chen, et al.
Oncogene|January 3, 2022
RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibitionWanting Han, Mingyu Liu, Dong Han, et al.
Nucleic Acids Research|January 8, 2017
Positive feedback loop mediated by protein phosphatase 1α mobilization of P-TEFb and basal CDK1 drives androgen receptor in prostate cancerXiaming Liu, Yanfei Gao, HuiHui Ye, et al.
Molecular Cancer Therapeutics|March 21, 2025
Heterogeneous Responses to High-Dose Testosterone in Castration-Resistant Prostate Cancer Tumors with Mixed Rb-Proficient and Rb-Deficient CellsMaryam Labaf, Wanting Han, Songqi Zhang, et al.
Cancer Research|March 6, 2023
LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate CancerMuqing Li, Mingyu Liu, Wanting Han, et al.
Cell Reports|October 21, 2016
Androgen Receptor Tumor Suppressor Function Is Mediated by Recruitment of Retinoblastoma ProteinShuai Gao, Yanfei Gao, Housheng Hansen He, et al.
The Journal of Clinical Investigation|April 5, 2016
SOX9 drives WNT pathway activation in prostate cancerFen Ma, Huihui Ye, Housheng Hansen He, et al.
Cancer Research|August 27, 2011
Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitorsChangmeng Cai, Sen Chen, Patrick Ng, et al.
The Journal of Clinical Investigation|February 22, 2013
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancerChangmeng Cai, Hongyun Wang, Housheng Hansen He, et al.
Pageof 6